How close is evidence to truth in evidence-based treatment of mental disorders?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 4, 2012, Pages 277-289

  Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Evidence; Evidence based medicine (EBM); Mental disorders; Truth

Indexed keywords

ANTIDEPRESSANT AGENT; LAMOTRIGINE;

ARTICLE; BIPOLAR DEPRESSION; DEPRESSION; EMPIRICAL RESEARCH; EVIDENCE BASED MEDICINE; EXTERNAL VALIDITY; HUMAN; INTERNAL VALIDITY; MANIA; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL SOCIETY; MENTAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PUBLICATION; SUICIDE; THEORETICAL STUDY;

CLINICAL TRIALS AS TOPIC; DECISION THEORY; DISEASE MANAGEMENT; EMPIRICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; META-ANALYSIS AS TOPIC; PHILOSOPHY; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; SEMANTICS;

EID: 84864938665     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0273-8     Document Type: Article

References (95)

1. American Psychiatric Association APA Guideline Development Process (2006) http://www.psych.org/psych-pract/treatg/pg/prac- guide.cfm.Anonymous
2. Antes G (2004) The evidence base of clinical practice guidelines, health technology assessments and patient information as a basis for clinical decision-making. Z Ärztl Fortbild Qualitätssich 98:180-184 (Pubitemid 38823183)
3. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D et al (2004) Grading quality of evidence and strength of recommendations. BMJ 19:1490
4. Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253: 22-28 (Pubitemid 37205221)
5. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J, Hollander E, Kasper S, Moller HJ, Bandelow B et al (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive- compulsive and post-traumatic stress disorders-first revision. World J Biol Psychiatry 9:248-312
6. Bandelow B, Zohar J, Kasper S, Möller HJ (2008) How to grade categories of evidence. World J Biol Psychiatry 9:242-247
7. Bateman A, Fonagy P (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156:1563-1569 (Pubitemid 29459988)
8. Bauer M, Whybrow PC, Angst J (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3:69-86
9. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Möller HJ, WFSBP Task Force on Unipolar Depressive Disorders (2007) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 8:67-104 (Pubitemid 46690921)
10. Bauer M, Tharmanathan P, Volz HP, Mö ller HJ, Freemantle N (2009) The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a metaanalysis. Eur Arch Psychiatry Clin Neurosci 259(3):172-185
11. Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5-43
12. Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR (2008) Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials. Br J Psychiatry 192(1):5-11 (Pubitemid 351183154)
13. Bottlender R, Rudolf D, Strauss A, Moller HJ (1998) Antidepressant- associated maniform states in acute treatment of patients with bipolar-I depression. Eur Psychiatry 248:296-300 (Pubitemid 29026985)
14. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321:694-696
15. Carnap R (1956) The methodological character of theoretical concepts. In: Feigl HSM (ed) Minnesota studies on the philosophy of science. 1. Minneapolis, pp 38-76
16. Carnap R (1966) Philosophical foundations on physics. Gardner M, New York
17. Carpenter WT (2001) Evidence-based treatment for first-episode Schizophrenia? Am J Psychiatry 158:1771-1773 (Pubitemid 33054768)
18. Cartabellotta A, Minella C, Bevilacqua L, Caltagirone P (1998) Evidence-based medicine. 3. Systematic reviews: a tool for clinical practice, permanent education and health policy decisions. Italian Group on Evidence-Based Medicine-GIMBE. Recenti Prog Med 89:329-337
19. Cartabellotta A, Montalto G, Notarbartolo A (1998) Evidencebased medicine. How to use biomedical literature to solve clinical problems. Italian Group on Evidence-Based Medicine-GIMBE. Minerva Med 89:105-115 (Pubitemid 28331291)
20. Catty J, Burns T, Comas A (2001) Day centres for severe mental illness. Cochrane Database Syst Rev (2):CD001710
21. Chilvers R, Macdonald GM, Hayes AA (2002) Supported housing for people with severe mental disorders. Cochrane Database Syst Rev (2):CD000453
22. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H et al (2009) Comparative efficacy and acceptability of 12 newgeneration antidepressants: a multiple-treatments meta-analysis. Lancet 373:746-758
23. Clark W, Mucklow J (1998) Gathering and weighing the evidence. In: Panton R, Chapman S (eds) Medicines management. BMJ Books and Pharmaceutical Press, London, pp 59-74
24. Craig JC, Irwig LM, Stockler MR (2001) Evidence-based medicine: Useful tools for decision making. MJA 174:248-253 (Pubitemid 32197419)
25. Crowther R, Marshall M, Bond G, Huxley P (2003) Vocational rehabilitation for people with severe mental illness (Cochrane Review) [computer program]. The Cochrane Library, Issue 3. Update Software, Oxford
26. Czekalla J (2006) Kritische Bewertung von Studien und Metaanalysen. Ein Fortbildungsartikel über die wichtigsten Validitätskriterien der Evidence-basedMedicine. Psychopharmakotherapie 13:224-230 (Pubitemid 44899587)
27. Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553-564 (Pubitemid 36682312)
28. Deutsche Gesellschaft fü r Psychiatrie PuN DGPPN, BÄK, KBV, AWMF, AkdÄB, BApK, DAGSHG, DEGAM, DGPM, DGPs et al (eds) (2009) S3-Leitlinien/Nationale VersorgungsLeitlinie Unipolare Depression. Berlin, Düsseldorf. Deutsche Gesellschaft fü r Psychiatrie, Psychotherapie und Nervenheilkunde
29. Eccles M, Grimshaw J, Campbell M, Ramsay C (2003) Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care 12:47-52 (Pubitemid 36241256)
30. Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Moller HJ (2006) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia. World J Biol Psychiatry 7:5-40 (Pubitemid 43878525)
31. Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Moller HJ, WFSBP Task Force on Treatment Guidelines for Schizophrenia (2005) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry 6:132-191
32. Fountoulakis KN, Möller HJ (2011) Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol 14:405-412
33. Fritze J, Möller HJ (2001) Design of clinical trials of antidepressants. Should a placebo control arm be included? CNS Drugs 15:755-764 (Pubitemid 33065426)
34. Geddes JR, Calabrese JR, Goodwin GM (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4-9
35. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653-661 (Pubitemid 36246547)
36. Gerson S, Belin TR, Kaufman A, Mintz J, Jarvik L (1999) Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings. Harv Rev Psychiatry 7:1-28 (Pubitemid 29426049)
37. Gonzalez DD (2001) From evidence-based medicine to medicinebased evidence. An Esp Pediatr 55:429-439
38. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Möller HJ (2002) World Federation of Societies of Biological Psychiary (WFSBP) guidelines for biological treatment of bipolar disorders, Part I: Treatment of bipolar depression. World J Biol Psychiatry 3:115-124
39. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Moller HJ (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II: Treatment of mania. World J Biol Psychiatry 4:5-13
40. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ (2004) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part III: Maintenance treatment. World J Biol Psychiatry 5:120-135 (Pubitemid 44121706)
41. Grunze H, Vieta E, Guy M, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 10(2): 85-116
42. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129:174-181 (Pubitemid 43265259)
43. Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schutze M, Scheunemann W, Allgaier AK, Coyne J, Henkel V (2010) Effects of pharmacotherapy and psychotherapy in depressed primarycare patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 13:31-44
44. Hegerl U, Plattner A, Moller HJ (2004) Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s. Eur Arch Psychiatry Clin Neurosci 254:99-107 (Pubitemid 39304477)
45. Horder J, Matthews P, Waldmann R (2010) Placebo, Prozac and PLoS: significant lessons for psychopharmacology. J Psychopharmacol [Epub ahead of print]
46. Huf W, Kalcher K, Pail G, Friedrich ME, Filzmoser P, Kasper S (2011) Meta-analysis: fact or fiction? How to interpret metaanalyses. World J Biol Psychiatry 12:188-200
47. Jadad AR, Phil D, Cook DJ (1998) Methodology and reports of systematic reviews and meta-analyses-a comparison of cochrane reviews with articles published in paper-based Journals. JAMA 280:278-280 (Pubitemid 28493907)
48. Kallert TW (2005) Is mental health services research in need of randomised controlled trials? Psychiatr Prax 32:375-377 (Pubitemid 41807751)
49. Kawamura T, Tamakoshi A, Wakai K, Ohno Y (1999) Evidencebased medicine and 'The Cochrane Collaboration'. Nippon Koshu Eisei Zasshi 46:498-506
50. Khan KS, Kunz R, Kleijnen J, Antes G (2004) Systematische ü bersichten und Meta-Analysen. Ein Handbuch für Ärzte in Klinik und Praxis sowie Experten im Gesundheitswesen. Springer, Berlin
51. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 5:e45
52. Klein DF (2000) Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 157:1204-1211 (Pubitemid 30659800)
53. Koller M, Lorenz W, Abel U (2006) Methodenvielfalt in der klinischen Forschung. MMW-Fortschritte der Medizin 148: 85-91
54. Leichsenring F, Rabung S, Leibing E (2004) The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 61:1208-1216 (Pubitemid 39602837)
55. Leucht S, Arbter D, Engel RR, Kissling W, Davis JM (2009) How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry 14(4):429-447
56. Lieberman JA, Greenhouse J, Hamer RM, Krishnan KR, Nemeroff CB, Sheehan DV, Thase ME, Keller MB (2005) Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology 30:445-460 (Pubitemid 40271148)
57. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223 (Pubitemid 41345943)
58. Linden M (2002) Verhaltenstherapie: theoretische und empirische Grundlagen sowie klinische Anwendungsprinzipien. In: Möller HJ, Laux G, Kapfhammer HP (eds) Psychiatrie and psychotherapie. Springer, Berlin, pp 681-710
59. Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N (2006) Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 63:757-766
60. Lohr KN (2004) Rating the strength of scientific evidence: relevance for quality improvement programs. Int J Qual Health Care 16:9-18 (Pubitemid 38239816)
61. Maier W, Möller HJ (2005) Metaanalyses-highest level of empirical evidence? Eur Arch Psychiatry Clin Neurosci 255: 369-370
62. Maier W, Möller HJ (2010) Meta-analyses: a method to maximise the evidence from clinical studies? Eur Arch Psychiatry Clin Neurosci 260:17-23
63. Manser R, Walters EH (2001) What is evidence-based medicine and the role of the systematic review: the revolution coming your way. Monaldi Arch Chest Dis 56:33-38 (Pubitemid 32457887)
64. Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D (2003) Day hospital versus admission for acute psychiatric disorders. Cochrane Database Syst Rev (1):CD004026
65. Marshall M, Gray A, Lockwood A, Green R (2003) Case management for people with severe mental disorders (Cochrane Review). The Cochrane Library, Issue 3. Update Software, Oxford
66. Marshall M, Lockwood A (2003) Assertive communication treatment for people with severe mental disorder (Cochrane Review). The Cochrane Library, Issue 3. Update Software, Oxford
67. Mittelstraß JH (2004) Evidenz. In: Mittelstraß J (ed) Enzyklopädie Philosophie und Wissenschaftstheorie. Sonderausgabe ed. J. B.Metzler, Stuttgart, pp 609-610
68. Mittelstraß JH (2004) Wahrheit. In: Mittelstraß J (ed) Enzyklopädie Philosophie und Wissenschaftstheorie. Sonderausgabe ed. J. B.Metzler, Stuttgart, pp 582-587
69. Mittelstraß JH (2004) Wahrheitsähnlichkeit. In: Mittelstraß J (ed) Enzyklopädie philosophie und wissenschaftstheorie. Sonderausgabe ed. J. B.Metzler, Stuttgart, pp 588-589
70. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896-1900
71. Möller HJ (1976) Methodische Grundprobleme der Psychiatrie. Kohlhammer, Stuttgart
72. Möller HJ (1978) Psychoanalyse. Erklärende Wissenschaft oder Deutungskunst? Zur Grundlagendiskussion in der Psychowissenschaft. Fink, München
73. Möller HJ (2001) Methodological issues in psychiatry: psychiatry as an empirical science. World J Biol Psychiatry 2:38-47
74. Möller HJ (2006) Methodik empirischer Forschung und evidenzbasierter Medizin in der Psychiatrie. In: Möller HJ, Laux G, Kapfhammer HP (eds) Psychiatrie und psychotherapie. 3 Aufl. Springer, Berlin
75. Möller HJ (2008) Do effectiveness (''real world'') studies on antipsychotics tell us the real truth? Eur Arch Psychiatry Clin Neurosci 258:257-270
76. Möller HJ (2008) Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 258:451-455
77. Möller HJ (2009) Is evidence sufficient for evidence-based medicine? Eur Arch Psychiatry Clin Neurosci 259(Suppl 2): S167-S172
78. Möller HJ, Broich K (2010) Principle standards and problems regarding proof of efficacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci 260:3-16
79. Möller HJ, Fuger J, Kasper S (1993) Statistische metaanalyse der Wirksamkeit neuerer Antidepressiva. Antidepressiva und Phasenprophylaktika. Riederer P, Laux G, and Pöldinger W. Neuro- Psychopharmaka.Wien, Springer, pp 252-256
80. Möller HJ, Maier W (2010) Evidence-based medicine in psychotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260:25-39
81. Montgomery SA, Möller HJ (2009) Is the significant superiority of escitalopram compared with other antidepressants cliniclly relevant? Int Clin Psychopharmacol 24:111-118
82. Neumann PJ, Tunis SR (2010) Medicare and medical technology- the growing demand for relevant outcomes. N Engl J Med 362:377-379
83. Pilling S, Price K (2006) Developing and implementing clinical guidelines: lessons from the NICE schizophrenia guideline. Epidemiol Psichiatr Soc 15:109-116 (Pubitemid 44047700)
84. Popper K (1963) Conjectures and refutations. The growth of scientific knowledge. Routledge & Kegan Paul, London
85. Riedel M, Strassnig N, Müller N, Zwack P, Möller HJ (2005) How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psychiatry Clin Neurosci 255:143-148 (Pubitemid 40558606)
86. Sackett DL (2000) Evidence-Based Medicine: How to practice and teach EBM. Churchill Livingstone, New York
87. Sackett DL, Richardson S, Rosenberg WS, Haynes W, Dt. Ausg: Kunz R, Fritsche L (1999) Evidenzbasierte Medizin. Zuckschwerdt, München
88. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn't. BMJ 312:71-72
89. Saha S, Coffman DD, Smits AK (2010) Giving teeth to comparative- effectiveness research-the Oregon experience. N Engl J Med 362:e18
90. Schmacke N (2006) Evidenzbasierte Medizin und Psychotherapie: die Frage nach den angemessenen Erkenntnismethoden. Psychother Psychosom Med Psychol 56:202-209 (Pubitemid 44517789)
91. Schöchlin C, Möller HJ, Engel RR (2002) Meta-Analysen von Antidepressiva-Studien. In: Riederer P, Laux G, Pöldinger W (eds) Neuro-psychopharmaka, Bd. 3, 2. Aufl. Springer, Wien New York, pp 349-363
92. Seemüller F, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W et al (2010) Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. J Clin Psychiatry 71:1426-1433
93. Stegmü ller W (1954) Metaphysik, Wissenschaft, Skepsis. Frankfurt, Wien
94. Tarski A (1935) Der Wahrheitsbegriff in den formalisierten Sprachen. Stud Philos 1:262-405
95. Wampold BE, Minami T, Baskin TW, Callen TS (2002) A meta- (re)analysis of the effects of cognitive therapy versus 'other therapies' for depression. J Affect Disord 68:159-165 (Pubitemid 34628323)